结缔组织病相关间质性肺病中医研究进展  

Progress in Traditional Chinese Medicine Research on Connective Tissue Disease-Associated Interstitial Lung Disease

作　　者：柏溪峻 杨善军[2] 

机构地区：[1]黑龙江中医药大学研究生院,黑龙江 哈尔滨 [2]黑龙江中医药大学附属第二医院肺病科,黑龙江 哈尔滨

出　　处：《中医学》2024年第12期3587-3594,共8页Traditional Chinese Medicine

摘　　要：间质性肺病(Interstitial Lung Disease, ILD)是一组以肺泡炎和肺纤维化为基本病理改变的疾病的总称,其病因尚不完全明确,在已经明确病因的ILD中,由结缔组织病(Connective Tissue Disease, CTD)继发的间质性肺病尤为常见。因此结缔组织病相关性间质性肺病(Connective Tissue Disease-Associated Interstitial Lung Disease, CTD-ILD)的诊疗这一话题逐渐被人们所关注,然而在西医的诊查手段越来越丰富的今天,其治疗手段却仍旧限于免疫抑制剂、糖皮质激素、抗纤维化药物等比较有局限的途径,疗效也很难达到令人满意的效果。中医学以其独特的诊疗思路和手段,能够在一定程度上弥补西医治疗的不足,更好地缓解患者痛苦。祖国传统医学对于该病的研究有着悠久的历史,当代医家在前人的著作中撷英拾萃,结合各自的临床经验,运用中医药治疗CTD-ILD取得了很好的疗效。现笔者针对近年来中医在CTD-ILD诊疗方面所取得的进展作一综述,以作参考。Interstitial Lung Disease (ILD) is a general term for a group of diseases with pulmonary inflammation and fibrosis as the basic pathological changes. Its etiology is not yet fully understood. Among ILD with a clear etiology, interstitial lung disease secondary to Connective Tissue Disease (CTD) is particularly common. Therefore, the diagnosis and treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD) has gradually attracted people’s attention. However, with the increasingly diverse diagnostic methods in Western medicine, its treatment methods are still limited to immunosuppressive agents, glucocorticoids, anti-fibrotic drugs, and other relatively limited approaches, and the efficacy is also difficult to achieve satisfactory results. Traditional Chinese medicine, with its unique diagnostic and therapeutic approaches, to some extent, can compensate for the shortcomings of Western medicine treatment and better alleviate patients’ pain. Tra

关 键 词：结缔组织病相关间质性肺病 中医 肺痹 肺萎 研究进展 

分 类 号：R56[医药卫生—呼吸系统]